U S Physical Therapy Inc (USPH) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
U S Physical Therapy Inc  (NYSE: USPH)

U S Physical Therapy Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for U S Physical Therapy Inc in the third quarter 2026?
U S Physical Therapy Inc achieved a return on average equity (ROE) of 9.48 % in its third quarter 2026, which is below U S Physical Therapy Inc's average return on equity, which stands at 15.92%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 42 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 1111 to 1332.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Equity Change -14.8 % -10.58 % -5.92 % -2.68 % -
Y / Y Net Income Change -37.39 % -15.93 % -39.44 % -26.56 % 80.44 %
Net Income (TTM) in Millions 43 50 53 58 61
Return On Equity (TTM) 9.48 % 10.5 % 10.79 % 11.7 % 12.29 %
USPH's Total Ranking # 1332 # 1111 # 937 # 807 #
Equity (TTM) in Millions 430 449 469 477 505
Seq. Equity Change -4.25 % -4.32 % -1.56 % -5.53 % 0.5 %
Seq. Net Income Change -25.86 % 82.66 % -11.11 % -47.99 % -0.44 %

Back to USPH Management Effectiveness >> USPH's 5 Years Annual ROE >> Compare USPH ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 43
Sector # 145
Overall # 1332

Return On Equity Statistics
High Average Low
26.18 %
15.92 %
6.6 %
(Jun 30 2019)   (Sep 30 2024)





USPH Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 477 490 477 317 297
Y / Y Equity Change -2.68 % 2.64 % 50.58 % 6.69 % 7.04 %
Net Income in Millions 58 46 37 43 58
Y / Y Net Income Change 27.2 % 22.51 % -14.25 % -25.06 % 10.35 %
Return On Equity 12.16 % 9.31 % 7.8 % 13.69 % 19.49 %

Back to USPH Management Effectiveness >> USPH's 5 Years Annual ROE >> Compare USPH ROE to its Competitors




Annual Roe Comment
In 2025 ROE improved to 12.16 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
USPH's' Return on Equity at Yahoo Finance
USPH's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for USPH's Competitors
Subscribers only: Roe for U S Physical Therapy Inc's Suppliers
Subscribers only: Return On Equity for USPH's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %
Corcept Therapeutics Inc  22.88 %
Msa Safety Inc  21.79 %
Lantheus Holdings Inc   21.72 %
Iqvia Holdings Inc   21.40 %
Denali Therapeutics Inc   21.40 %
West Pharmaceutical Services Inc   21.08 %
Brightspring Health Services Inc   20.31 %
Healthcare Services Group Inc   20.22 %
Vertex Pharmaceuticals Inc  20.08 %
Ge Healthcare Technologies Inc   20.04 %
Neurocrine Biosciences Inc   19.74 %
Ani Pharmaceuticals Inc  19.70 %
Johnson and Johnson  19.55 %
Pediatrix Medical Group Inc   17.28 %
Kiniksa Pharmaceuticals International Plc  17.27 %
Krystal Biotech Inc   17.02 %
Intuitive Surgical Inc   16.99 %
Ensign Group Inc  16.62 %
Lemaitre Vascular Inc   15.81 %
Stryker Corp  15.61 %
Quest Diagnostics Inc  15.22 %
Regeneron Pharmaceuticals Inc   15.07 %
Bio rad Laboratories Inc   14.07 %
Boston Scientific Corporation  13.75 %

Date modified: 2026-11-09T18:27:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.